Literature DB >> 24283584

TERT genetic polymorphism rs2736100 was associated with lung cancer: a meta-analysis based on 14,492 subjects.

Hui-Min Wang1, Xue-Yan Zhang, Bo Jin.   

Abstract

BACKGROUND: Previous studies focused on the association of the telomerase reverse transcriptase (TERT) gene polymorphism rs2736100 with lung cancer did not reach the same conclusion. In the present study, we performed a meta-analysis to systematically summarize the possible association between TERT polymorphism rs2736100 and the risk for lung cancer.
METHOD: We conducted a search of case-control studies on the association of TERT with susceptibility to lung cancer in PubMed, EMBASE, ISI Web of Science, Wanfang database in China, and Chinese National Knowledge Infrastructure (CNKI) databases. Data from eligible studies were extracted for meta-analysis. Lung cancer risk associated with rs2736100 was estimated by pooled odds ratios (ORs) and 95% confidence intervals (95% CIs).
RESULTS: Six independent case-control studies on rs2736100 were included in our meta-analysis. Our results showed that rs2736100 was associated with the risk of lung cancer not only in an additive model (OR=1.19, 95% CI: 1.04-1.35; p=0.01), but also in a dominant model (OR=1.14, 95% CI: 1.01-1.28; p=0.03).
CONCLUSIONS: This meta-analysis suggests that rs2736100 is associated with the risk of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24283584      PMCID: PMC3865617          DOI: 10.1089/gtmb.2013.0322

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  20 in total

Review 1.  Variation at the TERT locus and predisposition for cancer.

Authors:  Duncan M Baird
Journal:  Expert Rev Mol Med       Date:  2010-05-18       Impact factor: 5.600

2.  Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations.

Authors:  Daiki Miki; Michiaki Kubo; Atsushi Takahashi; Kyong-Ah Yoon; Jeongseon Kim; Geon Kook Lee; Jae Ill Zo; Jin Soo Lee; Naoya Hosono; Takashi Morizono; Tatsuhiko Tsunoda; Naoyuki Kamatani; Kazuaki Chayama; Takashi Takahashi; Johji Inazawa; Yusuke Nakamura; Yataro Daigo
Journal:  Nat Genet       Date:  2010-09-26       Impact factor: 38.330

Review 3.  Chromosome end maintenance by telomerase.

Authors:  Jennifer L Osterhage; Katherine L Friedman
Journal:  J Biol Chem       Date:  2009-03-12       Impact factor: 5.157

4.  Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers.

Authors:  Yufei Wang; Peter Broderick; Athena Matakidou; Timothy Eisen; Richard S Houlston
Journal:  Carcinogenesis       Date:  2009-12-02       Impact factor: 4.944

5.  Genetic polymorphisms of TERT and CLPTM1L and risk of lung cancer--a case-control study in a Chinese population.

Authors:  Ajay A Myneni; Shen-Chih Chang; Rungui Niu; Li Liu; Heather M Ochs-Balcom; Yanli Li; Chao Zhang; Baoxing Zhao; Jianping Shi; Xiaoyou Han; Jiawei Li; Jia Su; Lin Cai; Shunzhang Yu; Zuo-Feng Zhang; Lina Mu
Journal:  Lung Cancer       Date:  2013-02-19       Impact factor: 5.705

6.  Multiple variants of TERT and CLPTM1L constitute risk factors for lung adenocarcinoma.

Authors:  X F Chen; S Cai; Q G Chen; Z H Ni; J H Tang; D W Xu; X B Wang
Journal:  Genet Mol Res       Date:  2012-02-16

7.  A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma.

Authors:  Maria Teresa Landi; Nilanjan Chatterjee; Kai Yu; Lynn R Goldin; Alisa M Goldstein; Melissa Rotunno; Lisa Mirabello; Kevin Jacobs; William Wheeler; Meredith Yeager; Andrew W Bergen; Qizhai Li; Dario Consonni; Angela C Pesatori; Sholom Wacholder; Michael Thun; Ryan Diver; Martin Oken; Jarmo Virtamo; Demetrius Albanes; Zhaoming Wang; Laurie Burdette; Kimberly F Doheny; Elizabeth W Pugh; Cathy Laurie; Paul Brennan; Rayjean Hung; Valerie Gaborieau; James D McKay; Mark Lathrop; John McLaughlin; Ying Wang; Ming-Sound Tsao; Margaret R Spitz; Yufei Wang; Hans Krokan; Lars Vatten; Frank Skorpen; Egil Arnesen; Simone Benhamou; Christine Bouchard; Andres Metspalu; Andres Metsapalu; Tonu Vooder; Mari Nelis; Kristian Välk; John K Field; Chu Chen; Gary Goodman; Patrick Sulem; Gudmar Thorleifsson; Thorunn Rafnar; Timothy Eisen; Wiebke Sauter; Albert Rosenberger; Heike Bickeböller; Angela Risch; Jenny Chang-Claude; H Erich Wichmann; Kari Stefansson; Richard Houlston; Christopher I Amos; Joseph F Fraumeni; Sharon A Savage; Pier Alberto Bertazzi; Margaret A Tucker; Stephen Chanock; Neil E Caporaso
Journal:  Am J Hum Genet       Date:  2009-10-15       Impact factor: 11.025

8.  Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls.

Authors:  Darren R Brenner; Paul Brennan; Paolo Boffetta; Christopher I Amos; Margaret R Spitz; Chu Chen; Gary Goodman; Joachim Heinrich; Heike Bickeböller; Albert Rosenberger; Angela Risch; Thomas Muley; John R McLaughlin; Simone Benhamou; Christine Bouchardy; Juan Pablo Lewinger; John S Witte; Gary Chen; Shelley Bull; Rayjean J Hung
Journal:  Hum Genet       Date:  2013-02-01       Impact factor: 4.132

9.  Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer.

Authors:  Yongyu Wang; Phillip J Kuan; Chao Xing; Jennifer T Cronkhite; Fernando Torres; Randall L Rosenblatt; J Michael DiMaio; Lisa N Kinch; Nick V Grishin; Christine Kim Garcia
Journal:  Am J Hum Genet       Date:  2008-12-18       Impact factor: 11.025

10.  Systematic reviews of genetic association studies. Human Genome Epidemiology Network.

Authors:  Gurdeep S Sagoo; Julian Little; Julian P T Higgins
Journal:  PLoS Med       Date:  2009-03-03       Impact factor: 11.069

View more
  9 in total

1.  TERT rs2736100 polymorphism contributes to lung cancer risk: a meta-analysis including 49,869 cases and 73,464 controls.

Authors:  Wei Nie; Yuansheng Zang; Jiquan Chen; Qingyu Xiu
Journal:  Tumour Biol       Date:  2014-02-18

Review 2.  Lung adenocarcinoma: from molecular basis to genome-guided therapy and immunotherapy.

Authors:  Roberto Chalela; Víctor Curull; César Enríquez; Lara Pijuan; Beatriz Bellosillo; Joaquim Gea
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

3.  Tankyrase 1 polymorphism associated with an increased risk in developing non-small cell lung cancer in a Chinese population: a proof-of-principle study.

Authors:  Ying Wang; Weiyu Jiang; Xiaogu Liu; Yongjun Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

4.  Increased lung cancer risk associated with the TERT rs2736100 polymorphism: an updated meta-analysis.

Authors:  Jihua Yang; Shunchang Jiao
Journal:  Tumour Biol       Date:  2014-03-04

5.  Telomere reverse transcriptase (TERT) rs2735940 increases cancer risk.

Authors:  Hui Yang; Jing Li; Ruihua Tang; Yaxiong Liu; Yan Shao; Qingsheng Huang; Junling Shi
Journal:  Med Sci Monit       Date:  2015-02-26

6.  Combining Telomerase Reverse Transcriptase Genetic Variant rs2736100 with Epidemiologic Factors in the Prediction of Lung Cancer Susceptibility.

Authors:  Xu Wang; Kewei Ma; Lumei Chi; Jiuwei Cui; Lina Jin; Ji-Fan Hu; Wei Li
Journal:  J Cancer       Date:  2016-04-28       Impact factor: 4.207

7.  The TERT rs2736100 polymorphism increases cancer risk: A meta-analysis.

Authors:  Hui Li; Yanyan Xu; Hua Mei; Liang Peng; Xiaojie Li; Jianzhou Tang
Journal:  Oncotarget       Date:  2017-06-13

8.  Assessment of Telomerase Reverse Transcriptase Single Nucleotide Polymorphism in Sleep Bruxism.

Authors:  Piotr Macek; Mieszko Wieckiewicz; Rafal Poreba; Pawel Gac; Katarzyna Bogunia-Kubik; Marta Dratwa; Anna Wojakowska; Grzegorz Mazur; Helena Martynowicz
Journal:  J Clin Med       Date:  2022-01-20       Impact factor: 4.241

Review 9.  Telomere Maintenance Mechanisms in Cancer.

Authors:  Tiago Bordeira Gaspar; Ana Sá; José Manuel Lopes; Manuel Sobrinho-Simões; Paula Soares; João Vinagre
Journal:  Genes (Basel)       Date:  2018-05-03       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.